Tendonitis, Myositis and Bursitis DRG Reimbursement Guide

Acute procedural intervention trials investigating effectiveness and safety of minimally invasive tendon or bursa interventions (such as ultrasound-guided corticosteroid injections versus image-guided needle tenotomy) in hospitalized patients with severe tendonitis, myositis, or bursitis who have failed outpatient care; these studies enroll patients early in their inpatient course to measure short-term pain reduction, functional improvement, and avoidance of surgical escalation, and are relevant to providers and payers because demonstrated inpatient procedures that reduce length of stay or prevent higher-cost interventions can inform care pathways and resource allocation.
Comparative effectiveness trials of multimodal nonoperative management strategies for moderate-to-severe inflammatory soft-tissue disorders in medically complex inpatients, comparing combinations such as optimized physical therapy regimens, systemic anti-inflammatory strategies, and localized therapies; these studies focus on patients with comorbidities (eg, diabetes, obesity, anticoagulation) who may respond differently to conservative care and address which bundles of therapies improve function and reduce readmissions, providing evidence to guide inpatient protocols and reimbursement decisions.
Post-discharge outcomes and utilization studies examining long-term functional recovery, recurrence rates, outpatient rehabilitation needs, and healthcare utilization among patients discharged after inpatient treatment for tendonitis, myositis, or bursitis; these observational studies follow diverse populations (including older adults and those with work-related musculoskeletal issues) to identify predictors of readmission, durable functional outcomes, and cost drivers, which helps payers evaluate post-acute care benefits and providers design transitions of care that reduce downstream costs.

Acute procedural intervention trials investigating effectiveness and safety of minimally invasive tendon or bursa interventions (such as ultrasound-guided corticosteroid injections versus image-guided needle tenotomy) in hospitalized patients with severe tendonitis, myositis, or bursitis who have failed outpatient care; these studies enroll patients early in their inpatient course to measure short-term pain reduction, functional improvement, and avoidance of surgical escalation, and are relevant to providers and payers because demonstrated inpatient procedures that reduce length of stay or prevent higher-cost interventions can inform care pathways and resource allocation.
Comparative effectiveness trials of multimodal nonoperative management strategies for moderate-to-severe inflammatory soft-tissue disorders in medically complex inpatients, comparing combinations such as optimized physical therapy regimens, systemic anti-inflammatory strategies, and localized therapies; these studies focus on patients with comorbidities (eg, diabetes, obesity, anticoagulation) who may respond differently to conservative care and address which bundles of therapies improve function and reduce readmissions, providing evidence to guide inpatient protocols and reimbursement decisions.
Post-discharge outcomes and utilization studies examining long-term functional recovery, recurrence rates, outpatient rehabilitation needs, and healthcare utilization among patients discharged after inpatient treatment for tendonitis, myositis, or bursitis; these observational studies follow diverse populations (including older adults and those with work-related musculoskeletal issues) to identify predictors of readmission, durable functional outcomes, and cost drivers, which helps payers evaluate post-acute care benefits and providers design transitions of care that reduce downstream costs.

OpenPayer

Summary & Overview

Tendonitis, Myositis and Bursitis without MCC: Inpatient Reimbursement Overview

DRG 558 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes